855 related articles for article (PubMed ID: 16565636)
1. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
Lo Sasso AT; Rost K; Beck A
Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
[TBL] [Abstract][Full Text] [Related]
2. Impact of primary care depression intervention on employment and workplace conflict outcomes: is value added?
Smith JL; Rost KM; Nutting PA; Libby AM; Elliott CE; Pyne JM
J Ment Health Policy Econ; 2002 Mar; 5(1):43-9. PubMed ID: 12529569
[TBL] [Abstract][Full Text] [Related]
3. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
Vicente-Herrero T; Burke TA; Laínez MJ
Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
[TBL] [Abstract][Full Text] [Related]
4. The costs and benefits of enhanced depression care to employers.
Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
[TBL] [Abstract][Full Text] [Related]
5. Expanded mental health benefits and outpatient depression treatment intensity.
Lo Sasso AT; Lindrooth RC; Lurie IZ; Lyons JS
Med Care; 2006 Apr; 44(4):366-72. PubMed ID: 16565638
[TBL] [Abstract][Full Text] [Related]
6. Economic benefit of chemical dependency treatment to employers.
Jordan N; Grissom G; Alonzo G; Dietzen L; Sangsland S
J Subst Abuse Treat; 2008 Apr; 34(3):311-9. PubMed ID: 17614238
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of interventions for depressed Latinos.
Schoenbaum M; Miranda J; Sherbourne C; Duan N; Wells K
J Ment Health Policy Econ; 2004 Jun; 7(2):69-76. PubMed ID: 15208467
[TBL] [Abstract][Full Text] [Related]
8. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective.
Lamb CE; Ratner PH; Johnson CE; Ambegaonkar AJ; Joshi AV; Day D; Sampson N; Eng B
Curr Med Res Opin; 2006 Jun; 22(6):1203-10. PubMed ID: 16846553
[TBL] [Abstract][Full Text] [Related]
9. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance.
Birnbaum HG; Kessler RC; Kelley D; Ben-Hamadi R; Joish VN; Greenberg PE
Depress Anxiety; 2010; 27(1):78-89. PubMed ID: 19569060
[TBL] [Abstract][Full Text] [Related]
10. Response to an article in the April 2006 issue of Medical Care.
Persaud R
Med Care; 2006 Dec; 44(12):1148-9; author reply 1149. PubMed ID: 17122721
[No Abstract] [Full Text] [Related]
11. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.
Marseille E; Saba J; Muyingo S; Kahn JG
AIDS; 2006 Apr; 20(6):907-14. PubMed ID: 16549976
[TBL] [Abstract][Full Text] [Related]
12. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.
Joish VN; Donaldson G; Stockdale W; Oderda GM; Crawley J; Sasane R; Joshua-Gotlib S; Brixner DI
Curr Med Res Opin; 2005 Apr; 21(4):535-44. PubMed ID: 15899102
[TBL] [Abstract][Full Text] [Related]
13. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
14. Tegaserod treatment for IBS: a model of indirect costs.
Smith DG; Barghout V; Kahler KH
Am J Manag Care; 2005 Apr; 11(1 Suppl):S43-50. PubMed ID: 15926763
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
16. Labor Supply of Poor Residents in Metropolitan Miami, Florida: The Role of Depression and the Co-Morbid Effects of Substance Use.
Alexandre PK; French MT
J Ment Health Policy Econ; 2001 Dec; 4(4):161-173. PubMed ID: 12119426
[TBL] [Abstract][Full Text] [Related]
17. Total costs of IBS: employer and managed care perspective.
Cash B; Sullivan S; Barghout V
Am J Manag Care; 2005 Apr; 11(1 Suppl):S7-16. PubMed ID: 15926759
[TBL] [Abstract][Full Text] [Related]
18. A benefit-to-cost analysis of a work-site health promotion program.
Golaszewski T; Snow D; Lynch W; Yen L; Solomita D
J Occup Med; 1992 Dec; 34(12):1164-72. PubMed ID: 1464785
[TBL] [Abstract][Full Text] [Related]
19. Workplace smoking related absenteeism and productivity costs in Taiwan.
Tsai SP; Wen CP; Hu SC; Cheng TY; Huang SJ
Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i33-7. PubMed ID: 15923446
[TBL] [Abstract][Full Text] [Related]
20. A review of methods to measure health-related productivity loss.
Mattke S; Balakrishnan A; Bergamo G; Newberry SJ
Am J Manag Care; 2007 Apr; 13(4):211-7. PubMed ID: 17408341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
